Biosimilar - PDFSEARCH.IO - Document Search Engine

Biosimilar
Results: 639

#	Item
401	Subsequent entry biologics in Canada The case for multi-sector collaboration Roundtable Summary Report March[removed]Subsequent entry biologics in Canada\| 1 Add to Reading List Source URL: www.ppforum.ca Language: English - Date: 2014-04-11 07:09:16 Health Biosimilar Biologic Adverse effect Pharmacovigilance Pharmacology Medicine Pharmaceutical sciences
402	Order Code RL33901 Follow-On Biologics: Intellectual Property and Innovation Issues Add to Reading List Source URL: ipmall.info Language: English - Date: 2007-07-28 13:14:49 Medicine Pharmaceutical industry Pharmaceuticals policy Biotechnology Biosimilar Drug Price Competition and Patent Term Restoration Act New Drug Application Generic drug Biologic Pharmaceutical sciences Pharmacology Food and Drug Administration
403	Lost Prescription Drug Savings from Use of REMS Programs to Delay Generic Market Entry BY ALEX BRILL July 2014 Add to Reading List Source URL: www.gphaonline.org Language: English - Date: 2014-07-23 11:23:52 Pharmaceutical industry Pharmaceuticals policy Generic drug Food and Drug Administration Biosimilar Abbreviated New Drug Application Biologic New Drug Application Pharmaceutical sciences Pharmacology Clinical research
404	. Follow-On Biologics: Intellectual Property and Innovation Issues Wendy H. Schacht Specialist in Science and Technology Policy Add to Reading List Source URL: ipmall.info Language: English - Date: 2010-11-10 20:48:18 Pharmaceutical industry Food and Drug Administration Biotechnology Pharmaceuticals policy Biosimilar Drug Price Competition and Patent Term Restoration Act New Drug Application Generic drug Biologic Pharmaceutical sciences Pharmacology Clinical research
405	Order Code RL33901 Follow-On Biologics: Intellectual Property and Innovation Issues Add to Reading List Source URL: ipmall.info Language: English - Date: 2009-01-07 20:22:49 Food and Drug Administration Health Pharmaceutical industry Biotechnology Biosimilar Drug Price Competition and Patent Term Restoration Act New Drug Application Generic drug Biologic Pharmaceutical sciences Pharmacology Pharmaceuticals policy
406	InVitria Taps Industry Expert to Launch Cell Culture Supplements Product Line Fort Collins, CO January 20, 2011 – InVitria announced the expansion of its sales and marketing team with the addition of Shawn Smith as Vic Add to Reading List Source URL: www.midwestventure.com Language: English - Date: 2011-01-21 15:55:16 Cell lines Cell culture Life Technologies Invitrogen Stem cell Biosimilar Biologic Biology Biotechnology Cell biology
407	Order Code RL33901 Follow-On Biologics: Intellectual Property and Innovation Issues Add to Reading List Source URL: ipmall.info Language: English - Date: 2007-03-27 14:47:20 Medicine Pharmaceutical industry Pharmaceuticals policy Biotechnology Biosimilar Drug Price Competition and Patent Term Restoration Act New Drug Application Generic drug Biologic Pharmaceutical sciences Pharmacology Food and Drug Administration
408	. Follow-On Biologics: Intellectual Property and Innovation Issues Wendy H. Schacht Specialist in Science and Technology Policy Add to Reading List Source URL: ipmall.info Language: English - Date: 2009-08-26 19:15:17 Pharmaceutical industry Pharmaceuticals policy Food and Drug Administration Biotechnology Biosimilar Drug Price Competition and Patent Term Restoration Act New Drug Application Generic drug Biologic Pharmaceutical sciences Pharmacology Clinical research
409	Harvard Journal of Law & Technology Volume 25, Number 1 Fall 2011 THE DISPARATE EFFECTS OF GENE PATENTS ON DIFFERENT CATEGORIES OF SCIENTIFIC RESEARCH Abigail Lauer* Add to Reading List Source URL: jolt.law.harvard.edu Language: English - Date: 2012-01-12 22:54:12 Pharmacology Biotechnology Gene patent Genetics Patent law Myriad Genetics BRCA1 Biosimilar Patentable subject matter Medicine Biology Pharmaceutical sciences
410	Microsoft Word - Sorscher_Draft_post_round_4_2.doc Add to Reading List Source URL: jolt.law.harvard.edu Language: English - Date: 2011-02-11 21:39:45 Medicine Pharmaceutical industry Pharmaceuticals policy Clinical research Biosimilar Biologic New Drug Application Center for Drug Evaluation and Research Generic drug Pharmaceutical sciences Food and Drug Administration Pharmacology

UPDATE